Researchers at Massachusetts Institute of Technology (MIT) and the University of Colorado at Denver in the US are working on repurposing an existing blood clots drug to help patients at risk of respiratory failure.

The drug is a tissue plasminogen activator (tPA) used to help heart attack and stroke patients. Three hospitals in Massachusetts and Colorado intend to test the drug in severely ill Covid-19 patients.

Read the full article here